MDM4 and neoplasm: In a patient-derived xenograft (PDX) model of pancreatic carcinoma measuring 100 ± 25 mm3, this NP inhibited tumor growth by 85.7% within 10 days, and downregulation of MDMX was seen on histological analysis.